Lataa...
Toxicity and management in CAR T-cell therapy
T cells can be genetically modified to target tumors through the expression of a chimeric antigen receptor (CAR). Most notably, CAR T cells have demonstrated clinical efficacy in hematologic malignancies with more modest responses when targeting solid tumors. However, CAR T cells also have the capac...
Tallennettuna:
| Julkaisussa: | Mol Ther Oncolytics |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5008265/ https://ncbi.nlm.nih.gov/pubmed/27626062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2016.11 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|